MedPath

雅柏药业(中国)有限公司

Ownership
-
Established
1995-10-13
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Theophylline Sustained-release Tablets

Product Name
茶碱缓释片
Approval Number
国药准字H20033244
Approval Date
Apr 15, 2024
NMPA

Paracetamol,Pseudoephedrine Hydrochloride and Chlorphenamine Maleate Oral Solution

Product Name
氨酚伪麻那敏口服溶液
Approval Number
国药准字H20030465
Approval Date
Apr 15, 2024
NMPA

Clarithromycin for Suspension

Product Name
泰必捷
Approval Number
国药准字H20020365
Approval Date
Apr 15, 2024
NMPA

Dextromethorphan Hydrobromide, Chlorphenamine Maleate and Pseudoephedrine Hydrochloride Oral Solution

Product Name
美敏伪麻口服溶液
Approval Number
国药准字H20000693
Approval Date
Apr 15, 2024
NMPA

Ibuprofen Sustained-release Tablets

Product Name
怡芬宁
Approval Number
国药准字H19990352
Approval Date
Apr 15, 2024
NMPA

Salbutamol Sulfate Sustained-release Capsules

Product Name
赛比舒
Approval Number
国药准字H19990247
Approval Date
Apr 9, 2024
NMPA

Roxithromycin Capsules

Product Name
洛司美
Approval Number
国药准字H20060883
Approval Date
Apr 9, 2024
NMPA

Salbutamol Sulfate Sustained-release Capsules

Product Name
赛比舒
Approval Number
国药准字H19990246
Approval Date
Apr 9, 2024
NMPA

Roxithromycin Capsules

Product Name
洛司美
Approval Number
国药准字H20000219
Approval Date
Apr 9, 2024
NMPA

贝康安牌复合维生素B糖浆

Approval Number
卫食健字(2003)第0179号
Approval Date
Mar 7, 2003
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.